Certain antiarrhythmic drugs that inhibit myocardial repolarizing curr
ents decrease defibrillation energy, but the effect of blocking partic
ular currents on defibrillation is not well understood. We therefore i
nvestigated the effect of barium, a relatively selective blocker of in
wardly rectifying potassium current (Ik(1)) on voltage and energy requ
irements for defibrillation in an open-chest dog model. Defibrillation
energy and voltage requirements were assessed by delivering monophasi
c shocks through epicardial electrode patches at varying voltages to c
onstruct a dose-response curve of energy and voltage versus success in
defibrillation. The energy and voltage for 50% success in defibrillat
ion (E(50) and V-50, respectively) were determined by logistic regress
ion. Monophasic action potential duration at 90% repolarization (MAPD(
90)) was measured with a contact electrode, and ventricular refractory
period (VERP) was measured. After baseline measurements were obtained
of E(50), V-50, MAPD(90), and VERP, saline (control) (n = 6) or bariu
m (1.1 mg/kg/min for 5 min followed by 0.25 mg/kg/min) (n = 11) was ad
ministered. Defibrillation voltage and energy requirements and electro
physiologic measures were repeated after 30 and 120 min of barium or s
aline infusion. In control animals, there was no significant change wi
th time in V-50 (2.0 +/- 12.4 and -0.2 +/- 16.0% at 30 and 120 min, re
spectively), VERP(+3 +/- 5 and -2 +/- 3% at 30 and 120 min, respective
ly) or MAPD(90) (+1 +/- 4 and -2 +/- 6, at 30 and 120 min, respectivel
y). In contrast, after barium infusion, there was a significant decrea
se in V-50 both at 30 and 120 min (-21.8 +/- 19.2, -36.2 +/- 15.8%, p
< 0.001), in E(50) (decrease of -34.2 +/- 38 and -59.9 +/- 23% at 30 a
nd 120 min, respectively, p < 0.001), and increases in VERP (+20 +/- 4
and +22 +/- 4% at 30 and 120 min, p < 0.03) and in MAPD(90) (+15 +/-
6 and +15 +/- 4% at 30 and 120 min, p < 0.03). We conclude that relati
vely specific inhibition of inwardly rectifying potassium current mark
edly decreases defibrillation voltage and energy requirements at a dos
e that produces slight increases in ventricular refractoriness and MAP
D.